These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2516973)
61. Advances in Alzheimer's disease. Clarfield AM J Am Geriatr Soc; 1992 Feb; 40(2):188. PubMed ID: 1740605 [No Abstract] [Full Text] [Related]
62. An in vivo assessment of the brain in Alzheimer's disease. Frohman EM; van den Noort S West J Med; 1986 Apr; 144(4):476. PubMed ID: 3487173 [No Abstract] [Full Text] [Related]
64. The role of nerve growth factor in Alzheimer's disease. Everall IP; Kerwin R Psychol Med; 1990 May; 20(2):249-51. PubMed ID: 2356254 [No Abstract] [Full Text] [Related]
65. PLA2G6 mutations and Parkinson's disease. Tan EK; Ho P; Tan L; Prakash KM; Zhao Y Ann Neurol; 2010 Jan; 67(1):148. PubMed ID: 20186954 [No Abstract] [Full Text] [Related]
66. Radiomics approach in the neurodegenerative brain. Salvatore C; Castiglioni I; Cerasa A Aging Clin Exp Res; 2021 Jun; 33(6):1709-1711. PubMed ID: 31428998 [TBL] [Abstract][Full Text] [Related]
67. Alzheimer pathology in Parkinson's disease. Jellinger K Neurology; 1989 Jun; 39(6):874-5. PubMed ID: 2725894 [No Abstract] [Full Text] [Related]
68. Current theories on the cause of Parkinson's disease. Langston JW J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):13-7. PubMed ID: 2666574 [No Abstract] [Full Text] [Related]
69. Leuko-araiosis: an ancient term for a new problem. Hachinski VC; Potter P; Merskey H Can J Neurol Sci; 1986 Nov; 13(4 Suppl):533-4. PubMed ID: 3791068 [TBL] [Abstract][Full Text] [Related]
70. Increased Brain Volume: A Novel Biomarker of Neurodegeneration? DiFrancesco JC; Stanzani L Neurology; 2022 Apr; 98(16):649-650. PubMed ID: 35228330 [No Abstract] [Full Text] [Related]
71. Computed tomography in Alzheimer's disease. Burns A Lancet; 1993 Mar; 341(8845):601-2. PubMed ID: 8094836 [No Abstract] [Full Text] [Related]
72. COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration? Cavallieri F; Fioravanti V; Toschi G; Grisanti S; Napoli M; Moratti C; Pascarella R; Versari A; Fraternali A; Casali M; Paul JJ; Moro E; Bauer P; Zedde M; Valzania F J Neurol; 2022 Jan; 269(1):59-61. PubMed ID: 34216264 [No Abstract] [Full Text] [Related]
74. Interobserver variation in computed tomography of the brain. Lee D; Fox A; Vinuela F; Pelz D; Lau C; Donald A; Merskey H Arch Neurol; 1987 Jan; 44(1):30-1. PubMed ID: 3800718 [TBL] [Abstract][Full Text] [Related]
75. A new approach to the genetic analysis of nervous system diseases: retrospective genotyping of archival brains. Kösel S; Grasbon-Frodl EM; Graeber MB Prog Brain Res; 1998; 117():307-13. PubMed ID: 9932416 [No Abstract] [Full Text] [Related]
76. Neuronal degenerative mechanisms as clues to pathogenesis and treatment of Alzheimer's disease. Nixon RA Neurobiol Aging; 1994; 15 Suppl 2():S61-5. PubMed ID: 7700464 [No Abstract] [Full Text] [Related]
77. Leukoencephalopathy in normal and pathologic aging. Babikian VL; Kase C AJNR Am J Neuroradiol; 1987; 8(4):734. PubMed ID: 3113214 [No Abstract] [Full Text] [Related]
78. The brain and aging. Busse EW Clin Obstet Gynecol; 1986 Jun; 29(2):374-83. PubMed ID: 2872985 [No Abstract] [Full Text] [Related]
79. Strategies for the development of therapeutics for Alzheimer's disease. Davies P Neurobiol Aging; 1994; 15 Suppl 2():S53-4. PubMed ID: 7700461 [No Abstract] [Full Text] [Related]
80. More on repetitive behaviors in Parkinson's disease. Friedman JH Mov Disord; 2005 Apr; 20(4):509. PubMed ID: 15732121 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]